Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;26:758-763

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, X.-M.
Right arrow Articles by Forehand, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, X.-M.
Right arrow Articles by Forehand, C. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1995;26:758.)
© 1995 American Heart Association, Inc.


Articles

Enhanced Vascular Neuropeptide Y– Immunoreactive Innervation in Two Hypertensive Rat Strains

Xin-Min Fan; Edith D. Hendley; Cynthia J. Forehand

From the Departments of Molecular Physiology and Biophysics (X.-M.F., E.D.H.) and Anatomy and Neurobiology (C.J.F.), University of Vermont College of Medicine, Burlington.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract Considerable evidence indicates an enhanced sympathetic innervation of resistance arterial smooth muscle in the spontaneously hypertensive rat (SHR) compared with its normotensive Wistar-Kyoto (WKY) control. In addition to sympathetic hyperinnervation, an increased vascular innervation by neuropeptide Y–containing fibers, which are known to exert a vasoconstrictive and trophic action in vascular smooth muscle, has also been described. In addition to genetic hypertension, the SHR expresses hyperactive behavior and hyperreactivity to stress. To determine whether the enhanced neuropeptide Y–immunoreactive vascular innervation is specifically associated with hypertension and/or these behavioral abnormalities, four genetically related, inbred rat strains were used: SHR, which are hypertensive and hyperactive; WKY rats, which are neither hypertensive nor hyperactive; WKHA, which are hyperactive but normotensive; and WKHT, which are hypertensive but not hyperactive. The present study demonstrated that whereas the hypertensive strains (SHR and WKHT) exhibited smooth muscle hypertrophy in both superior mesenteric and caudal arteries in adulthood (10 months) but not at a prehypertensive age (1 month), both arteries exhibited significantly increased neuropeptide Y–immunoreactive innervation at both ages. It was further observed that the mesenteric artery in WKHA, a normotensive strain, had significant smooth muscle hypertrophy at 10 months; however, neuropeptide Y innervation in this artery was no different from that of WKY controls. The findings indicate that there is a cosegregation of neuropeptide Y hyperinnervation of the vasculature with the hypertensive phenotype, evident as early as 1 month of life in the hypertensive strains, and this should be considered further as a contributory factor in genetic hypertension. Vascular smooth muscle hypertrophy, while evident in adult hypertensive rats, was also observed in the mesenteric artery (but not the caudal artery) of adult WKHA rats, suggesting that other factors besides genetic hypertension, possibly hyperreactivity to stress, are responsible for this specific hypertrophic change in WKHA rats.


Key Words: neuropeptide Y • rats, inbred • WKY • SHR • WKHT • WKHA • mesenteric artery, superior


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Pathological changes of systemic vasculature, especially increased vessel wall thickness, play an important role in the increase in vascular resistance associated with chronic hypertension.1 Because sympathetic nerve activity has been shown to exert a trophic effect on the development of blood vessels,2 the vascular changes in the SHR may be related to increased sympathetic nerve activity.3 Indeed, substantial evidence indicates an enhanced density of noradrenergic innervation of cerebral,4 caudal,5 and mesenteric arteries6 7 of the SHR compared with the normotensive genetic control, the WKY. Consistent with these findings, catecholamine levels are elevated in extracts of the SHR mesenteric artery relative to WKY.8 9

In addition to noradrenergic innervation, vascular smooth muscle receives a peptidergic innervation by NPY-containing nerve fibers. NPY coexists with and is coreleased with norepinephrine and epinephrine in cardiovascular regulatory pathways in the nervous system.10 NPY exerts a direct vasoconstrictive action and also potentiates vasoconstriction induced by electrical stimulation or application of norepinephrine.11 12 Recently, Shigeri and Fujimoto13 demonstrated that NPY stimulated DNA synthesis in porcine aortic smooth muscle cells in a dose-dependent manner, which suggests that NPY also exerts a trophic effect on vascular smooth muscle. Together with the findings that NPY-containing nerve density is increased in the vasculature, including cerebral,14 mesenteric,15 16 and pancreatic arteries,17 it is likely that NPY is involved in the pathogenesis of hypertension in the SHR.

The SHR is the most commonly used animal model of genetic hypertension; its characteristics resemble those of human essential hypertension.18 However, compared with WKY controls, the SHR differs in many other characteristics besides hypertension; the most prominent of these are hyperactivity in a novel environment and hyperreactivity to stress.19 Hendley and Ohlsson19 succeeded in genetically separating the hypertensive trait from these behavioral abnormalities of the SHR, producing two new inbred strains, each expressing the one trait without the other: from a crossbreeding of SHR with WKY followed by recombinant, selected inbreeding, they developed the inbred WKHT rat strain, which is hypertensive but not hyperactive or hyperreactive, and the inbred WKHA strain, which is hyperactive/hyperreactive to stress but not hypertensive. The longitudinal patterns of hypertension in WKHT and hyperactivity in WKHA paralleled those of the SHR as determined from ages 4 to 6 weeks through 1 year.19 Together with the SHR, which expresses both hypertension and hyperactivity, and the WKY, which expresses neither, these four related, inbred strains are considered to be the most appropriate means available for seeking correlations of biological differences with either hypertension or the most prominent behavioral abnormalities of the SHR.

The primary aim of the present study was to examine quantitatively the NPY-containing innervation of superior mesenteric and caudal arteries from SHR, WKY, WKHA, and WKHT rats to determine whether the enhanced innervation by NPY-immunoreactive fibers in the vascular beds of the SHR is associated with inheritance of either hypertension and/or hyperactivity.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Male SHR, WKY, WKHA (F23-26), and WKHT (F20-23) rats were bred and maintained in a closed rat colony in the University of Vermont Animal Care Facility. The colony was maintained at constant temperature (23°C) and humidity (50%) with a 12:12-hour light-dark cycle. Water and food were available ad libitum. Blood pressure and activity measurements were routinely obtained for all animals in the colony at 3 months of age as a means of monitoring the phenotypic expression of the hypertension and hyperactive traits; in some cases, measurements were also made at other ages. Systolic pressure was determined as the average of 8 to 10 measurements in conscious, restrained, naive rats, at 37°C, with an occlusive tail cuff and a pressure transducer (Narco Scientific). The apparatus for determination of spontaneous activity in a novel environment is a square Lucite cage equipped with four sets of light beams and photocell detectors, described previously in detail.19 A digitized display recorded the number of interruptions of light beams made by the movements of the rats when they were placed in the activity cage. The number of light-beam breaks in a 15-minute session was taken as the activity score.

Tissue Preparation
Age-matched male rats from each strain (1 and 10 months old) were anesthetized with sodium pentobarbital (50 mg/kg IP) and perfused intracardially with 0.15 mol/L sodium chloride solution, followed by 4% paraformaldehyde in 0.1 mol/L PB, pH 7.4. Approximately 2 mm of superior mesenteric and caudal arteries, beginning at their starting point from the descending aorta, were dissected under a microscope and postfixed for 2 hours in 4% paraformaldehyde in PB. After being rinsed in PB, tissues were equilibrated in 30% sucrose in PB at 4°C. Tissues were then embedded in Tissue-Tek OCT compound (Miles Laboratories) and frozen rapidly on dry ice. Arteries were sectioned transversely at 20 µm on a cryostat, and every 10th section was thaw-mounted onto chrome alum–coated slides. Six to 10 sections were obtained from each animal for immunohistochemical staining.

Immunohistochemistry
After being rinsed in PBS (0.1 mol/L sodium phosphate, 0.15 mol/L sodium chloride, pH 7.4), sections were preincubated for 20 minutes in 10% normal goat serum containing 0.3% Triton X-100 and then incubated in rabbit anti-NPY (JH3)20 diluted 1:5000 in PBS at 4°C overnight. JH3 anti-NPY was generously provided by Dr Richard Mains (Department of Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, Md). After PB rinses, the sections were incubated in 1:100 biotinylated goat anti-rabbit IgG (Vector Laboratories) for 60 minutes, rinsed, and incubated with 1:200 avidin-biotinylated horseradish peroxidase complex (Vector Laboratories). Finally, sections were incubated in PB containing 0.05% diaminobenzidine for 20 minutes, followed by addition of 0.01% hydrogen peroxide and incubation for another 20 minutes. After being rinsed in PB, slides were dehydrated in ethanol and coverslipped with DPX mounting medium (BDH, Ltd).

Data Analysis
Sections were viewed via transmitted light microscopy, and images were televised with a video camera. Images were digitized with an image processing system and NEUROLUCIDA software.21 Output images and a mouse-driven cursor were displayed on a monitor to allow operator selection of an area in the visual field. The inner and outer surfaces of the vascular muscle layer were traced to determine the cross-sectional area of the smooth muscle layer of the artery and its lumen. The cross-sectional area of the smooth muscle layer was calculated as the difference between the areas derived from the inner and outer surfaces of the vascular muscle layer. The cross-sectional area of the NPY-immunoreactive nerve fiber layer was obtained in a similar fashion; in this case, the inner and outer perimeters of the NPY-containing nerve fiber layer were traced, and the difference between the two cross-sectional areas was taken as the cross-sectional area of the nerve fiber layer. Measuring the cross-sectional area of the entire NPY-immunoreactive fiber layer eliminated a major shortcoming noted when we tried to quantify innervation by counting the number of the NPY-staining fibers in a selected longitudinal area: the innervation had a very uneven distribution both around and along the artery, which made it difficult to sample equivalent selected longitudinal areas among the four strains. Instead, we chose to measure the entire area of the layer of NPY innervation surrounding the circumference of the artery, sampled equivalently throughout the same 2-mm segment of artery in all four strains.

Statistics
Data consisting of 6 to 10 measurements from each rat for each parameter of measurement were pooled, and the mean value was calculated and used in the final analysis. Thus, each rat contributed only one value for each parameter. In these and all other measurements, the four rat strains were compared by ANOVA, followed by Newman-Keuls multiple comparison test with significance set at P<.05. Grouping of subjects for ANOVAs was by strain and, in a separate analysis, by the phenotypic traits expressed by these strains: for the hypertensive trait, the hypertensive strains, SHR and WKHT, were combined and compared with the combined normotensive strains, WKY and WKHA. Similarly, for the hyperactivity trait, the hyperactive strains (SHR and WKHA combined) were compared with the nonhyperactive strains (WKY and WKHT combined).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Systolic pressure and activity scores were measured in the 10-month-old rats that had been used in this study when they were 3 months old (Table 1A). Systolic pressure was significantly higher in the hypertensive strains, SHR and WKHT, than in the normotensive strains, WKY and WKHA. Activity testing at 3 months indicated that WKHA and SHR were significantly more active than WKY and WKHT rats; the scores in WKHA rats exceeded even those of the SHR. The results of these determinations confirmed previous findings in the history of these homozygous strains: that SHR and WKHT are hypertensive; SHR and WKHA are hyperactive; and WKHA males, although normotensive, exhibit significant elevations in systolic pressure compared with WKY controls.19 This elevation in pressure has previously been linked to hyperreactivity of WKHA rats to the stress (restraint and heating) associated with blood pressure measurement by tail plethysmography. We showed this in a previous study in which WKHA rats had higher systolic pressures than WKY rats when tested by tail plethysmography; however, when blood pressure was tested several weeks later in these same rats after they were fitted with an indwelling catheter in the tail artery, WKHA rats when undisturbed had systolic pressures no different from those of the WKY controls.22


View this table:
[in this window]
[in a new window]
 
Table 1. Systolic Pressure and Spontaneous Activity Scores

Table 1B shows systolic pressures by tail plethysmography and activity scores in 4-week-old rats tested previously in our colony of homozygous strains; thus, these measurements were not obtained specifically from the 4-week-old rats of the present study. Systolic pressure did not differ significantly among the four strains at this age, as also reported by others using tail plethysmography in SHR and WKY.3 23 Nor was there any significant difference in pressures when the rats were grouped for the hypertensive trait (P=.17). In contrast, activity scores did show a significant main effect of strain (P<.01) at this young age and a highly significant effect of the hyperactivity trait (P=.0008).

In superior mesenteric and caudal arteries, no differences were observed among the strains in cross-sectional area of the lumen at either 1 month or 10 months of age (Tables 2 and 3). In all strains, the luminal area increased by {approx}40% in superior mesenteric arteries and 25% in caudal arteries between 1 and 10 months.


View this table:
[in this window]
[in a new window]
 
Table 2. Cross-sectional Area of Vascular Lumen, Smooth Muscle Layer, and NPY-Containing Nerve Fiber Layer in Superior Mesenteric Arteries


View this table:
[in this window]
[in a new window]
 
Table 3. Cross-sectional Area of Vascular Lumen, Smooth Muscle Layer, and NPY-Containing Nerve Fiber Layer in Caudal Arteries

In the superior mesenteric artery, the cross-sectional area of smooth muscle in all four strains was {approx}6x104 µm2 at 1 month (Table 2 and Figure). In each strain, the smooth muscle layer increased significantly in thickness from 1 to 10 months of age; however, the increase was greater in the SHR, WKHT, and WKHA compared with the WKY (Table 2 and Figure). Thus, in the WKY, the cross-sectional area of the smooth muscle layer at 10 months was 150% of that at 1 month, whereas in the SHR, WKHT, and WKHA, the cross-sectional area at 10 months was 250% of that at 1 month (Table 2). There was no significant difference in cross-sectional area of the superior mesenteric artery smooth muscle layer among SHR, WKHT, and WKHA at 10 months of age (Table 2).



View larger version (126K):
[in this window]
[in a new window]
 
Figure 1. NPY-immunoreactive innervation of the superior mesenteric artery from WKY, SHR, WKHT, and WKHA at 1 and 10 months of age. At 1 month, the hypertensive rats (SHR and WKHT) exhibit thicker NPY-immunoreactive nerve fiber layers (arrows) surrounding the superior mesenteric arteries compared with the normotensive strains. The thickness of the vascular smooth muscle layer is not different among the four strains at 1 month. At 10 months, there is significant vascular smooth muscle hypertrophy in both the hypertensive (SHR and WKHT) and hyperactive (SHR and WKHA) strains compared with the WKY. Increased NPY-immunoreactive innervation is seen in the hypertensive strains (SHR and WKHT) relative to the normotensive strains (WKY and WKHA). Bar=50 µm.

In the caudal artery, there was no significant main effect of strain on thickness of smooth muscle at either 1 or 10 months of age (Table 3). At 10 months, however, the hypertensive rats (SHR and WKHT combined) showed a significant hypertrophy of the caudal arterial smooth muscle layer (P=.014). One-month-old hypertensive rats did not show this hypertrophy; furthermore, there was no significant influence of the hyperactivity trait on smooth muscle layer thickness (P>.05 in each case).

In contrast to the similarity of luminal and smooth muscle layer areas, significant differences in NPY-immunoreactive innervation were observed: in superior mesenteric arteries at 1 month of age, both SHR and WKHT exhibited hypertrophied NPY-immunoreactive innervation relative to either WKY or WKHA (Table 2 and Figure). The cross-sectional area of the NPY-immunoreactive nerve layer surrounding the superior mesenteric artery increased fivefold to sevenfold in each strain from 1 to 10 months of age. Thus, at 10 months of age, the NPY innervation to the superior mesenteric artery remained significantly hypertrophied in the SHR and WKHT relative to either WKY or WKHA (Table 2 and Figure). In caudal arteries, a similarly enhanced innervation by NPY-containing nerves was observed in the hypertensive strains at both ages (P<.05 for the hypertensive trait at 1 and 10 months, Table 3).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
In the present study using four genetically related rat strains that express hypertension and hyperactivity in all possible combinations, we found that the NPY-immunoreactive nerve fiber layer surrounding the superior mesenteric artery was hypertrophied in SHR and WKHT relative to WKHA and WKY normotensive rats in both young and adult rats. This enhanced NPY-immunoreactive innervation of the vascular bed had apparently cosegregated with the hypertensive trait among the four strains. In contrast, vascular hypertrophy was observed in the superior mesenteric artery in both hypertensive and hyperactive strains at 10 months of age. In the caudal artery, the NPY-immunoreactive innervation was also significantly increased at both 1 and 10 months in hypertension (SHR and WKHT combined compared with WKHA and WKY normotensive strains combined); however, the extent of the increase was less than in the superior mesenteric vascular bed. Thus, different vascular beds in the four strains may show different patterns of NPY-immunoreactive innervation in hypertension, as has been reported for the SHR by others.3 15

Increased vascular resistance is the basic hemodynamic abnormality in chronic, stable, essential hypertension. Enhanced sympathetic activity may lead to a sustained increase in vascular resistance through a variety of physiological and adaptive mechanisms, one of which is that the released sympathetic transmitters, including norepinephrine and NPY, can cause sustained arterial vessel constriction as well as vascular hypertrophy. The trophic effect of adrenergic nerves on systemic vasculature has been confirmed by denervation experiments, in which it has been observed that vascular smooth muscle cell proliferation and wall-to-lumen ratio are attenuated and decreased, respectively, by ganglionectomy.2 NPY, which is coreleased with catecholamines in peripheral and central cardiovascular regulatory pathways, has a potentiating action on catecholaminergic vasoconstriction as well as a trophic effect on vascular smooth muscle, confirmed by the recent report that NPY exerted a direct stimulation of mRNA synthesis in vascular smooth muscle cells.13 Our findings that the NPY-immunoreactive innervation in the peripheral arteries was enhanced in hypertensive rat strains suggest that abnormal disposition of NPY, like norepinephrine, might contribute to the development and maintenance of hypertension.

In the present study, we found that the increase in the cross-sectional area of the superior mesenteric vascular smooth muscle in SHR, WKHT, and WKHA relative to WKY was not present at 1 month of age but was significant at 10 months. In contrast to the mesenteric vessels, significant hypertrophy of the caudal arterial muscle layer correlated only with the hypertensive trait. As found for the superior mesenteric artery, no hypertrophy of the caudal artery was present at 1 month. In addition, Peruzzi et al24 reported that in the large conductive blood vessels, aorta and carotid artery, adult SHR and WKHT exhibited vascular hypertrophy, whereas WKHA vessels did not.

Our findings that vascular wall hypertrophy is not present in 4-week-old hypertensive rat strains are consistent with those of Lee,3 who found similar results in SHR compared with WKY. When WKHA and WKHT rats were added as additional genetic controls, it was surprising to note that WKHA rats, whose systolic pressures are not hypertensive but are nevertheless significantly higher than in WKY when measured by tail plethysmography, had increased medial wall thickness in the mesenteric vascular bed. The hypertrophic changes reported here in adult WKHA mesenteric artery (but not caudal artery) have not as yet been explored further; however, they are likely to be related to the hyperreactivity trait of WKHA rats, particularly their increased sympathetic–adrenal medullary responsiveness to stress22 and hyperreactivity of blood pressure, heart rate, and peripheral resistance increase in response to stress.25 Thus, although the WKHA has resting blood pressure not different from that of the WKY,22 repetitive stress responses may have increased the lifetime average pressure such that a secondary hypertrophy is present in the mesenteric arterial bed. The lack of an enhanced innervation in response to this hypertrophy is striking, because increases in target size are generally associated with a concomitant increase in innervation.26 27 28

It is generally believed that the growth of sympathetic nerves is regulated by NGF, which is supplied to neurons via their terminals, after its production and release by cells within target effector tissues. NGF levels were increased in the spleen and mesenteric vascular bed of the SHR compared with the WKY in both young and adult rats29 30 ; NGF may be involved in the early enhanced sympathetic innervation in the blood vessels of SHR. This hypothesis was further confirmed by recent findings that tissues with enhanced sympathetic innervation, including renal and mesenteric vasculature in SHR, were associated with an increased expression of NGF mRNA.31 Since the enhanced NPY innervation cosegregated with the hypertensive phenotype in the two new strains, it will be important to show whether this increase in the expression of NGF mRNA also cosegregates with hypertension.

In the present study, we found that the enhanced innervation of NPY-containing nerves in the superior mesenteric arteries of SHR was specifically associated with the inheritance of the hypertensive trait. This NPY-immunoreactive hyperinnervation in hypertensive rats was present in weanlings (1 month) when no hypertrophy of vascular muscle layer was found, whereas both hypertrophy and hyperinnervation of NPY-containing nerves were apparent in the adult (10 months). Thus, enhanced NPY innervation of the vasculature may be a contributing factor in the development of hypertension.


*    Selected Abbreviations and Acronyms
 
NGF = nerve growth factor
NPY = neuropeptide Y
PB = sodium phosphate buffer
SHR = spontaneously hypertensive rats
WKHA = rat strain that is hyperactive/hyperreactive to stress but not hypertensive
WKHT = rat strain that is hypertensive but not hyperactive or hyperreactive
WKY = Wistar-Kyoto rats<\/.>


*    Acknowledgments
 
This study was supported by NIH grant NS 26390 to Dr Hendley and American Heart Association grant 92011300 to Dr Forehand. We thank Drs Victor May and Karen M. Braas for their helpful discussion and comments.


*    Footnotes
 
Reprint requests to Dr Cynthia J. Forehand, Department of Anatomy and Neurobiology, College of Medicine, University of Vermont, Burlington, VT 05405.

Received March 13, 1995; first decision April 27, 1995; accepted August 3, 1995.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Folkow B. ‘Structural factor’ in primary and secondary hypertension. Hypertension. 1990;16:89-101.

2. Bevan RD. Effect of sympathetic denervation on smooth muscle proliferation in the growing rabbit ear artery. Circ Res. 1975;37:14-19. [Abstract/Free Full Text]

3. Lee RMKW. Vascular changes at the prehypertensive phase in the mesenteric arteries from spontaneously hypertensive rats. Blood Vessels. 1985;22:105-126. [Medline] [Order article via Infotrieve]

4. Lee TJ, Saito A. Altered cerebral vessel innervation in the spontaneously hypertensive rat. Circ Res. 1984;55:392-403. [Abstract/Free Full Text]

5. Cassis LA, Stitzel RE, Head RJ. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms. J Pharmacol Exp Ther. 1985;234:792-803. [Abstract/Free Full Text]

6. Lee RMKW, Forrest JB, Garfield RE, Daniel EE. Morphometric study of structural changes in the mesenteric blood vessels of spontaneously hypertensive rats. Blood Vessels. 1983;20:245-254. [Medline] [Order article via Infotrieve]

7. Scott TM, Pang SC. The correlation between the development of sympathetic innervation and the development of medial hypertrophy in jejunal arteries in normotensive and spontaneously hypertensive rats. J Auton Nerv Syst. 1983;8:25-32. [Medline] [Order article via Infotrieve]

8. Donohue SJ, Stitzel RE, Head RJ. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats. J Pharmacol Exp Ther. 1987;245:24-31. [Abstract/Free Full Text]

9. Head RJ, Cassis LA, Robinson RL, Westfall DP, Stitzel RE. Altered catecholamine contents in vascular and nonvascular tissues in genetically hypertensive rats. Blood Vessels. 1985;22:196-204. [Medline] [Order article via Infotrieve]

10. Lehmann J. Neuropeptide Y: an overview. Drug Dev Res. 1990;19:329-351.

11. Duesler JG, Daly RN, Hieble JP. Studies on the mechanisms of neuropeptide Y induced potentiation of neurogenic vasoconstriction in the isolated rabbit ear artery. Am J Hypertens. 1990;3:796-800. [Medline] [Order article via Infotrieve]

12. Fallfren B, Edvinsson L, Ekblad E, Ekman R. Involvement of perivascular neuropeptide Y nerve fibers in uterine arterial vasoconstriction in conjunction with pregnancy. Regul Peptides. 1989;24:119-130. [Medline] [Order article via Infotrieve]

13. Shigeri Y, Fujimoto M. Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells. Neurosci Lett. 1993;149:19-22. [Medline] [Order article via Infotrieve]

14. Dhital KK, Gerli R, Lincoln J, Milner P, Tanganelli P, Weber G, Fruschelli C, Burnstock G. Increased density of perivascular nerves to the major cerebral vessels of the spontaneously hypertensive rat: differential changes in noradrenaline and neuropeptide Y during development. Brain Res. 1988;444:33-45. [Medline] [Order article via Infotrieve]

15. Kawamura K, Ando K, Takebayashi S. Perivascular innervation of the mesenteric artery in spontaneously hypertensive rats. Hypertension. 1989;14:660-665. [Abstract/Free Full Text]

16. Lee RMKW, Nagahama M, Mckenzie R, Daniel EE. Peptide-containing nerves around blood vessels of stroke-prone spontaneously hypertensive rats. Hypertension. 1988;11(suppl I):I-117-I-120.

17. Fujimoto C, Ito M, Sekine I. Noradrenergic and neuropeptide Y-immunoreactive nerves in the pancreatic islets of spontaneously hypertensive rats. Regul Peptides. 1993;47:171-178. [Medline] [Order article via Infotrieve]

18. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res. 1981;48:309-319. [Free Full Text]

19. Hendley ED, Ohlsson WG. Two new inbred rat strains derived from SHR: WKHA, hyperactive, and WKHT, hypertensive, rats. Am J Physiol. 1991;261(Heart Circ Physiol 30):H583-H589.

20. Braas KM, Hendley ED. Anterior pituitary proopiomelanocortin expression is decreased in hypertensive rat strains. Endocrinology.. 1994;134:196-205. [Abstract/Free Full Text]

21. Glaser JR, Glaser EM. Neuron imaging with neurolucida-APC-based system for image combining microscopy. Comput Med Imaging Graph. 1990;14:239-247.

22. Hendley ED, Cierpial MA, McCarty R. Sympathetic-adrenal medullary response to stress in hypertensive and hyperactive rats. Physiol Behav. 1988;44:47-51. [Medline] [Order article via Infotrieve]

23. Lais LT, Rios LL, Boutellee S, DiBona GF, Brody HJ. Arterial pressure development in neonatal and young spontaneously hypertensive rats. Blood Vessels. 1977;14:277-284. [Medline] [Order article via Infotrieve]

24. Peruzzi D, Hendley ED, Forehand CJ. Hypertrophy of stellate ganglion cells in hypertensive, but not hyperactive, rats. Am J Physiol. 1991;261(Regul Integr Comp Physiol 30):R979-R984.

25. Knardahl S, Hendley ED. Association between cardiovascular reactivity to stress and hypertension or behavior. Am J Physiol. 1990;259(Heart Circ Physiol 28):H248-H257.

26. Purves D, Snider WD, Voyvodic JT. Trophic regulation of nerve cell morphology and innervation in the autonomic nervous system. Nature. 1988;336:123-128. [Medline] [Order article via Infotrieve]

27. Voyvodic JT. Peripheral target regulation of dendritic geometry in the rat superior cervical ganglion. J Neurosci. 1989;9:1997-2010. [Abstract]

28. Steers WD, Kolbeck S, Creedon D, Tuttle JB. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest. 1991;88:1709-1715.

29. Ueyama T, Hamada M, Hano T, Nishio I, Masuyama Y, Furukawa S. Increased nerve growth factor levels in spontaneously hypertensive rats. J Hypertens. 1992;10:215-219. [Medline] [Order article via Infotrieve]

30. Zettler C, Rush RA. Elevated concentrations of nerve growth factor in heart and mesenteric arteries of spontaneously hypertensive rats. Brain Res. 1993;614:15-20. [Medline] [Order article via Infotrieve]

31. Falckh PH, Harkin LA, Head RJ. Nerve growth factor mRNA content parallels altered sympathetic innervation in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol. 1992;19:541-545.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, Z. Chen, R. R. Lachapelle, E. D. Hendley, and M. M. LeWinter
Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H463 - H473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. B. Clemow, W. D. Steers, R. McCarty, and J. B. Tuttle
Altered regulation of bladder nerve growth factor and neurally mediated hyperactive voiding
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1279 - R1286.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, X.-M.
Right arrow Articles by Forehand, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, X.-M.
Right arrow Articles by Forehand, C. J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure